Deal sells 5 million shares through Barclays, UBS and Piper Jaffray
By Devika Patel
Knoxville, Tenn., Jan. 25 - LipoScience, Inc. said it priced a $45 million initial public offering of stock with a $6.75 million greenshoe. The deal was announced on Thursday.
The company will sell 5 million common shares at $9.00 per share.
Barclays Capital Inc., UBS Securities LLC and Piper Jaffray & Co. are the joint bookrunning managers.
Proceeds will be used to hire additional sales and marketing personnel and to support costs associated with increased sales and marketing activities, for capital expenditures, including components of the Vantera system, research and development programs, to pay accrued dividends on preferred stock and the balance for other general corporate purposes, including general and administrative expenses, working capital and potential debt repayment.
LipoScience, based in Raleigh, N.C., develops and markets new clinical applications of NMR spectroscopy in the areas of cardiovascular disease and metabolic disorders.
| Issuer: | LipoScience, Inc.
|
| Issue: | Common stock
|
| Amount: | $45 million
|
| Greenshoe: | $6.75 million
|
| Shares: | 5 million
|
| Price: | $9.00
|
| Warrants: | No
|
| Announcement date: | Jan. 25
|
| Stock symbol: | Nasdaq: LPDX
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
